Showing results (1-10 of 1) with videos related to
Sort By:
Pageof 1
Journal of the Neurological Sciences|June 12, 2025
Ocrelizumab as first-line therapy in highly active relapsing-remitting multiple sclerosisTamar Kvartskhava, David Freudenstein, Nicolas Sarmiento, et al.Pageof 1